Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Ross

Showing results (141-150 of 244) with videos related to

Pageof 25
Sort By:
Journal of Proteome Research|August 4, 2016
Quantitative Proteomic Analysis Reveals Similarities between Huntington's Disease (HD) and Huntington's Disease-Like 2 (HDL2) Human BrainsTamara Ratovitski, Raghothama Chaerkady, Kai Kammers, et al.
Neurobiology of Disease|July 17, 2007
A mutant ataxin-3 fragment results from processing at a site N-terminal to amino acid 190 in brain of Machado-Joseph disease-like transgenic miceVeronica F Colomer Gould, Daniel Goti, Donna Pearce, et al.
The Journal of Biological Chemistry|December 5, 2002
Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicityFrederick C Nucifora, Lisa M Ellerby, Cheryl L Wellington, et al.
Neuron|July 6, 2005
p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's diseaseByoung-Il Bae, Hong Xu, Shuichi Igarashi, et al.
The Journal of Biological Chemistry|January 7, 2011
A compact beta model of huntingtin toxicityQi Charles Zhang, Tzu-Lan Yeh, Alfonso Leyva, et al.
Experimental Neurology|April 15, 2004
Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic miceGabriele Schilling, Alena V Savonenko, Michael L Coonfield, et al.
Neurobiology of Disease|August 7, 2010
Cerebral cortex structure in prodromal Huntington diseasePeggy C Nopoulos, Elizabeth H Aylward, Christopher A Ross, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2006
Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDHByoung-Il Bae, Makoto R Hara, Matthew B Cascio, et al.
Journal of Cellular Physiology|March 18, 2020
GTP-binding inhibitors increase LRRK2-linked ubiquitination and Lewy body-like inclusionsJoseph M Thomas, Xiaobo Wang, Gongbo Guo, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 19, 2020
Impaired response of cerebral oxygen metabolism to visual stimulation in Huntington's diseasePeter Klinkmueller, Martin Kronenbuerger, Xinyuan Miao, et al.
Pageof 25

Showing results (141-150 of 244) with videos related to

Sort By:
Pageof 25
Journal of Proteome Research|August 4, 2016
Quantitative Proteomic Analysis Reveals Similarities between Huntington's Disease (HD) and Huntington's Disease-Like 2 (HDL2) Human BrainsTamara Ratovitski, Raghothama Chaerkady, Kai Kammers, et al.
Neurobiology of Disease|July 17, 2007
A mutant ataxin-3 fragment results from processing at a site N-terminal to amino acid 190 in brain of Machado-Joseph disease-like transgenic miceVeronica F Colomer Gould, Daniel Goti, Donna Pearce, et al.
The Journal of Biological Chemistry|December 5, 2002
Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicityFrederick C Nucifora, Lisa M Ellerby, Cheryl L Wellington, et al.
Neuron|July 6, 2005
p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's diseaseByoung-Il Bae, Hong Xu, Shuichi Igarashi, et al.
The Journal of Biological Chemistry|January 7, 2011
A compact beta model of huntingtin toxicityQi Charles Zhang, Tzu-Lan Yeh, Alfonso Leyva, et al.
Experimental Neurology|April 15, 2004
Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic miceGabriele Schilling, Alena V Savonenko, Michael L Coonfield, et al.
Neurobiology of Disease|August 7, 2010
Cerebral cortex structure in prodromal Huntington diseasePeggy C Nopoulos, Elizabeth H Aylward, Christopher A Ross, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2006
Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDHByoung-Il Bae, Makoto R Hara, Matthew B Cascio, et al.
Journal of Cellular Physiology|March 18, 2020
GTP-binding inhibitors increase LRRK2-linked ubiquitination and Lewy body-like inclusionsJoseph M Thomas, Xiaobo Wang, Gongbo Guo, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 19, 2020
Impaired response of cerebral oxygen metabolism to visual stimulation in Huntington's diseasePeter Klinkmueller, Martin Kronenbuerger, Xinyuan Miao, et al.
Pageof 25